Testicular cancer: Increasing in incidence and curability

Patient Care

Volumn 34, Issue 10, 2000, Pages 18-37

  Foster, Richard ^a   Nichols, Craig ^b   Shhnfeld, Joel ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24644511328     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Bergstrom R, Adami HO, Mohner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996;88:727-733.
2. Collette L, Sylvester RJ, Stenning SP, et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. J Natl Cancer Inst. 1999;91:839-846.
3. Akre O, Ekbom A, Hsieh CC, et al. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst. 1996;88:883-889.
4. Sonneveld DJ, Koops HS, Sleijfer DT, et al. Surgery versus surveillance in stage I non-seminoma testicular cancer. Semin Surg Oncol. 1999;17:230-239.
5. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst. 1997;89:1429-1439.